Market revenue in 2023 | USD 4.9 million |
Market revenue in 2030 | USD 8.7 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 53.06% in 2023. Horizon Databook has segmented the Venezuela deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Low awareness about prevention and treatment of neurological disorders and mental illness is a major factors restraining market growth over the forecast period. Less number of medical facilities and surgeries being performed in the country is also limiting the market growth.
Thus, the demand for deep brain stimulation devices is low in the country. Furthermore, limited number of key players operating in the market is one of the major factors impeding market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account